Biotech News

Exagen Inc. to Participate in Upcoming Investor Conferences

Exagen (XGN)Exagen2026-10-29 13:00 ESTCompany update

CARLSBAD, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, today announced that management will participate in and meet with investors at the following investor conferences: Canaccord Genuity’s MedTech, Diagnostics and Digital

Related news

XGNExagen2026-10-27 13:00 EST

Exagen to Announce Third Quarter Financial Results on November 10, 2026

ENTAEnanta Pharmaceuticals2026-11-04 12:00 EST

Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences

BDSXBiodesix2026-11-04 11:00 EST

Biodesix to Participate in Upcoming Investor Conferences

CABACabaletta Bio2026-11-03 13:00 EST

Cabaletta Bio to Participate in Upcoming Investor Conferences

AVTXAvalo Therapeutics2026-11-02 21:00 EST

Avalo Therapeutics to Participate in Upcoming Investor Conferences

GPCRStructure Therapeutics2026-09-03 11:30 EST

Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences

KYMRKymera2026-09-02 20:01 EST

Kymera Therapeutics to Participate in Upcoming September Investor Conferences

SABSSAB Biotherapeutics2026-09-01 12:30 EST

SAB BIO to Participate in Upcoming Investor Conferences

NRIXNurix Therapeutics2026-09-01 12:00 EST

Nurix Therapeutics to Participate in Upcoming September Investor Conferences

ALECAlector2026-09-03 20:05 EST

Alector to Participate in Upcoming Healthcare Conferences

View all latest news

Exagen

Autoimmune Diagnostics Exagen provides diagnostic testing for autoimmune and rheumatic diseases. Its tests are designed to help clinicians resolve diagnostically complex cases and support ongoing disease management. AVISE CTD AVISE CTD is the company's flagship testing service for lupus and other connective-tissue diseases. It combines...

Recent company news

XGNExagen2026-10-29 13:00 EST

Exagen Inc. to Participate in Upcoming Investor Conferences

XGNExagen2026-10-27 13:00 EST

Exagen to Announce Third Quarter Financial Results on November 10, 2026

XGNExagen2026-08-04 12:00 EST

Exagen Inc. Reports Second Quarter 2026 Financial Results

XGNExagen2026-07-28 13:00 EST

Exagen Inc. to Participate in Upcoming Investor Conference

XGNExagen2026-07-21 13:00 EST

Exagen to Announce Second Quarter Financial Results on August 4, 2026

Stock data

Close: 7.60 USD
Market cap: 116.45M USD
Exchange: NASDAQ
Sector: MedTech
Location: United States